CONTRATHION

This brand name is authorized in Estonia, France, Tunisia, Turkey.

Active ingredients

The drug CONTRATHION contains one active pharmaceutical ingredient (API):

1
UNII FQO9PAV523 - PRALIDOXIME METHYL SULFATE
 
Read more about Pralidoxime

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V03AB04 Pralidoxime V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1284511
FR Base de données publique des médicaments 65724318
TN Direction de la Pharmacie et du Médicament 7273011H
TR İlaç ve Tıbbi Cihaz Kurumu 8699839790019

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈